Driven to improve lives. #DiscoverDicerna
Location: United States, Massachusetts, Lexington
Employees: 201-500
Phone: 6176218097
Total raised: $159M
Founded date: 2007
Investors 7
Funding Rounds 4
| Date | Series | Amount | Investors |
| 30.03.2017 | - | $70M | - |
| 01.08.2013 | Series C | $60M | - |
| 21.10.2010 | Series B | $4M | - |
| 11.08.2010 | Series B | $25M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 04.03.2024 | Beta Catenin Market Key Players, Demand and Growth Trends by... | Beta Catenin Market growth BURLINGAME, CALIFORNIA, UNITED STATES, March 4, 2024 /EINPresswire.com/ -... | einpresswi... |
| 30.03.2017 | Dicerna Scores $70M | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer ... | citybizlis... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 18.10.2013 | Health IT deals help push software deals to 12-year high but... | Here were the biggest health IT deals for the quarter based on data from the MoneyTree Report and Me... | medcitynew... |
| 01.08.2013 | Dicerna grabs $60M round to test RNAi tech on prime cancer s... | Dicerna Pharmaceuticals has topped up its financial reserves with a $60 million C round earmarked to... | fiercebiot... |
| 01.08.2013 | Dicerna Pharmaceuticals Inks $60M Series C | WATERTOWN, MA, Emerging pharmaceutical company developing RNA interference (RNAi)-based therapeuti... | vcnewsdail... |
| 01.08.2013 | Dicerna Secures $60 Million in Oversubscribed Series C Finan... | domainvc.c... | |
| 01.08.2013 | Dicerna Pharmaceuticals Raises $60M in Series C Financing | Dicerna Pharmaceuticals, Inc., a Watertown, Mass.-based biopharmaceutical company developing RNA int... | finsmes.co... |
| 21.10.2010 | Dicerna Pharmaceuticals Secures Additional $4M in Series B F... | Dicerna Pharmaceuticals, Inc., a Watertown MA-based second generation RNA interference (RNAi) compan... | finsmes.co... |
| 11.08.2010 | Dicerna Pharmaceuticals Closes $25M Series B Round of Financ... | Dicerna Pharmaceuticals, Inc., a Watertown, Massachusetts-based RNAi-focused biopharmaceutical compa... | finsmes.co... |
Show more